Navigation Links
Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System
Date:5/20/2008

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, regulatory approvals, competitive offerings, product performance and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
2. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
3. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... FORT WORTH, Texas , May 28, 2015 /PRNewswire/ ... defines and segments the concerned market with analysis and ... million in 2014 and is estimated to reach $1,177.8 ... 2014 to 2019. Browse through the TOC ... the industry trends and segments, with help of various ...
(Date:5/28/2015)... Colo. , May 28, 2015  Array BioPharma ... encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the ... which will be held May 29 – June 2, ... three products are currently advancing in a total of ... from both the NEMO (binimetinib monotherapy in NRAS mutant ...
(Date:5/28/2015)... , May 28, 2015  Pharmaceutic Labs announces ... under section 503B of the FDA,s Drug Quality ... the company is subject to Current Good Manufacturing ... medications according to the highest standards of CGMP ... 211. To continuously comply with FDA regulations and ...
Breaking Medicine Technology:Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3
... LAS VEGAS, BASKING RIDGE, N.J., and TOTOWA, N.J., Jan. ... (CES), Verizon Wireless and VectraCor, Inc. today said the ... booth (Las Vegas Convention Center, South Hall, Booth #30259).  ... ambulatory cardiac monitor that incorporates an electrocardiogram (ECG) amplifier ...
... 10, 2012  Wells Pharmacy Network President, Robert L. ... opening of Wells Pharmacy,s corporate headquarters. Located in ... pharmacy is focused on serving the unique needs ... Compounding combines the art and skill of pharmacy with the ...
Cached Medicine Technology:Verizon Wireless' Network Supports VectraCor's Ambulatory Cardiac Monitor 2Verizon Wireless' Network Supports VectraCor's Ambulatory Cardiac Monitor 3"Wells Pharmacy Network" a Premier Compounding Pharmacy Focused on Serving the Unique Needs of the Medical and Veterinarian Communities Opens in Wellington 2
(Date:5/28/2015)... Medelis, Inc., a specialty oncology CRO ... in the role of president. , “ Bill Taaffe ... industry,” said Larry Flanagan, Medelis’ CEO and co-founder. “He will ... next phase of growth.” , Taaffe joined ICON’s U.S. ... employees to over 4,500 employees, achieving 12 consecutive years of ...
(Date:5/28/2015)... May 28, 2015 ISMETT , a ... Italy, boosted the Sicilian economy by €132.5 million in expenditure ... benefit of more than €73 million by retaining patients who ... to a new study by the Battelle Memorial Institute. At ... research, training and advanced health care management that is transforming ...
(Date:5/28/2015)... Trends Investing ” was featured on NewsWatch as part of ... medium, and large businesses making an impact in their industry. ... the business review and shared with viewers how this website ... money. , The idea, “let your money work for you” ... how to succeed are two different things. So if ...
(Date:5/28/2015)... May 28, 2015 Senior Housing Assistance ... Lou Piniella, who managed the Seattle Mariners team that ... will appear in television and digital advertising for SHAG ... apartment communities, including several new communities slated to open ... Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. , ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Ticket Down is ... soccer match between Mexico and Argentina in early ... the world will compete on the pitch at AT&T Stadium ... another in an international friendly on Tuesday, September 8th at ... talented nations in the world including some of the most ...
Breaking Medicine News(10 mins):Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3
... competition behind almost 60% of cases, study finds ... high school athletes in the United States are ... , The researchers looked at football, soccer, volleyball, ... injuries accounted for just 8 percent of all ...
... study published in Journal of the American Geriatrics Society ... populations may be associated with cognitive decline. The study examined ... drug used to treat a variety of disorders that include ... aged 65 years or older with high blood pressure. ...
... BIRMINGHAM, Ala., Jan. 26 HealthSouth,Corporation (NYSE: HLS ... Global High Yield & Leveraged Finance Conference on Feb. 2-4, ... Chief Financial Officer John Workman will be speaking on,Tuesday, Feb. ... live and may,be accessed via the Investor Information section on ...
... while crossing streets are at a higher risk for injuries ... University of Alabama at Birmingham (UAB) in a new study ... . , "Cell phones clearly offer convenience and safeguards to ... when children attempt to multitask while conversing on the cell ...
... people have the right to clean air. Action ... may soon be able to breathe easier, said Dr. ... Alliance for Hispanic Health, the nation,s leading Hispanic health ... a Presidential Memorandum to the Environmental Protection Agency (EPA) ...
... /PRNewswire/ -- Alma Lasers Ltd. ("Alma"), ... devices, announced today the FDA clearance and immediate ... is the fifth module available on the Accent(TM) ... FDA clearance for "the temporary reduction in the ...
Cached Medicine News:Health News:HS Sports Shoulder Injuries More Likely in Boys 2Health News:Common medication associated with cognitive decline in elderly 2Health News:Cell phones dangerous for child pedestrians, UAB study finds 2Health News:Statement on Presidential Memorandum to EPA to Review Lifting of Ban on California Clean Car Standard 2
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
ELP 40- 8 Way Head Strip Plate Washer....
Finstruments 96 well washer and Cellwasher. Multi-function with touch programmable display....
The Finstrip 4 is an effective and reliable microplate washer offering high performance, simplicity and ease of use....
Medicine Products: